By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Mobius Therapeutics Lands $3M for Eye Surgery Drug Kits
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Finance > Mobius Therapeutics Lands $3M for Eye Surgery Drug Kits
BusinessFinance

Mobius Therapeutics Lands $3M for Eye Surgery Drug Kits

Deanna Pogorelc
Deanna Pogorelc
Share
2 Min Read
SHARE

eye surgery drug kitsFirst published on MedCityNews.com. Now that it’s gotten some sales traction and a fresh round of capital, Mobius Therapeutics is ready to double its sales forceeye surgery drug kitsFirst published on MedCityNews.com. Now that it’s gotten some sales traction and a fresh round of capital, Mobius Therapeutics is ready to double its sales force and ramp up education efforts for Mitosol, its first product for eye surgeons.

What Mobius has done is take the drug mitomycin c, which ophthalmologists have been using for years off-label, and package it into a standard dosage kit that can be stored at room temperature for up to 24 months. The FDA has approved the kit for use in glaucoma surgery, and Mobius is pursuing additional applications in two other kinds of eye procedures.

St. Louis-based Cultivation Capital has just led a $3 million Series B for the company to support its expansion efforts.

“Having achieved critical regulatory, commercial, and market milestones, this investment will allow Mobius to accelerate the adoption of Mitosol, thereby improving convenience, occupational safety, consistency of patient treatment, and economics for patients, providers, and ophthalmologists,” Mobius President and CEO Ed Timm said in a statement.

More Read

Choosing Well: Patient Challenges in Choosing a Physician in a Rapidly Changing World
7 Things You Should Not Do When Creating Your Health Website
Expansion of Medicare Rewards Adds Key Tool to Drive Behavior Change
Give Forward – a Social Solution for Out of Pocket Medical Care
The Paradox in American Healthcare

Glaucoma is one of the most common causes of blindness in the U.S. Medicines and surgeries are used to slow the progression of the disease by reducing pressure in the eyes.

Mitomycin c, which was initially introduced to the market as a chemotherapeutic agent, is used during surgery to prevent scarring that can block the drainage holes formed during surgery.

The St. Louis company last raised money in the fall of last year. Since then, it’s also received a payment indicator from CMS.

TAGGED:health start-ups!Mobius Therapeutics
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

Can YOU Innovate Healthcare? Critical Info For Startups

June 3, 2013
medicaid
BusinessFinanceHealth ReformHospital AdministrationMedical EthicsPolicy & LawPublic Health

Making a 5% Commitment to Medicaid

November 21, 2013
venture capital
BusinessFinancePolicy & Law

Venture Capital Fantasyland: Venrock’s Proposal to Reform Drug Development

April 27, 2014
Image
BusinessHospital AdministrationMobile HealthSocial Media

Strategy and Practice Intertwine in a New Social Media Book by the Mayo Clinic

November 20, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?